# A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis

> **NCT02057289** · PHASE1 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 9 (actual)

## Conditions studied

- Immunocompromised
- Bone Marrow Transplant
- Cancer

## Interventions

- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT02057289
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2018-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057289, "A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02057289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*